SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is surging following record quarterly revenue and the milestone achievement of positive operating cash flow, signaling a significant transition toward profitability. Investors are actively discussing the company's strategic pivot into semiconductor-based licensing and its growing AI-integrated imaging partnerships.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following the announcement of a joint research agreement with Honda, which confirms that another major automotive OEM has successfully completed technical benchmarking of the company's solid-state battery technology. While the community is debating the timeline of this partnership, investors are closely watching for further OEM disclosures and updates on manufacturing scale as the stock attempts to build momentum on this latest validation.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is facing intense downward pressure and volatility as investors weigh a strong quarterly earnings report against concerns that emerging AI agentic tools could disrupt its core SaaS business model. While some in the community see the stock as a deeply undervalued 'steal' supported by strong cash reserves and institutional accumulation, others are aggressively betting on further downside, citing an ongoing rotation out of traditional software and fears that AI-native startups will erode future growth.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is trending as investors monitor ongoing institutional interest, geopolitical tensions affecting market liquidity, and broader shifts in regulatory sentiment. Community discussions are heavily focused on technical chart patterns and speculative debates over whether Bitcoin acts as a reliable inflation hedge compared to traditional equities.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mount Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics is trending as the community closely monitors the company's pending acquisition of the Covelya Group and anticipates a significant revenue boost in upcoming earnings. Investors remain highly bullish on the stock's long-term defense-sector tailwinds and institutional growth, with many actively accumulating shares during recent market volatility in anticipation of future exchange uplistings.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is trending as investors weigh an abrupt leadership transition to a new CEO following a period of performance challenges against the stock's deep-value valuation and aggressive insider buying. The community remains sharply divided between those viewing the price level as a historic entry point for long-term recovery and those concerned that the fintech giant is struggling with structural growth headwinds.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently trending due to intense community debate over its extreme price volatility and poor performance compared to other assets, leading many to speculate about further downside risks. Investors are actively discussing the project's long-term utility in real-world asset tokenization versus concerns over tokenomics, inflation, and a perceived lack of buying interest.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is currently the subject of intense community debate as investors weigh the company's path to an NDA submission for AXPAXLI against pending litigation from competitor EyePoint Pharmaceuticals. While bulls remain encouraged by recent regulatory alignment and the potential for a first-in-class product, others are focused on the stock's recent volatility and broader market pressure on the biotech sector.

Roundhill ETF Trust - Roundhill Memory ETF

DRAM is trending as investors aggressively pivot toward memory infrastructure, viewing it as the primary supply bottleneck for the ongoing AI buildout. The community is actively debating the durability of this "memory supercycle" and analyzing the impact of potential structural shifts in supply-demand dynamics as traders prepare for upcoming earnings and industry-specific catalysts.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is trending as traders speculate on its potential role in autonomous defense software and recent volatility, with community sentiment deeply divided between bullish investors banking on government contracts and bearish voices dismissing the stock as a heavily manipulated pump-and-dump scheme. Active discussions are heavily focused on the stock's wild price swings, the impact of recent geopolitical tensions on the drone sector, and intense debates over whether its limited revenue justifies its current valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CELC Stock Records Worst Day Ever After Late-Stage Breast Cancer Trial Results — What’s Driving The Selloff?

Equity

The company reported three deaths in the trial, though none were associated with its experimental drug gedatolisib.


What's Going On With Celcuity Stock On Tuesday?

Celcuity reported Phase 3 data showing gedatolisib improved progression-free survival in PIK3CA-mutated breast cancer.read more...

Celcuity's Cancer Drug Expansion Could Ignite Massive New Market Opportunity: Analyst

Celcuity expands VIKTORIA-2 to endocrine-sensitive breast cancer patients and advances injectable gedatolisib formulation.read more...

Celcuity (CELC) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Celcuity (CELC) to Release Earnings on Wednesday

Celcuity (NASDAQ:CELC) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 13. (View Earnings Report at...

Celcuity, Inc. (NASDAQ:CELC) Given Consensus Rating of "Moderate Buy" by Analysts

Celcuity, Inc. (NASDAQ:CELC - Get Free Report) has earned an average recommendation of "Moderate Buy" from the twelve ratings firms that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have issu...

Best Biotech Stocks To Research - May 4th

Celcuity, Danaher, Vertex Pharmaceuticals, Rallybio, and Moderna are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies focused on developing biological products, drugs, diagnostics, or platform technologies...

Citizens Jmp Increases Celcuity (NASDAQ:CELC) Price Target to $160.00

Citizens Jmp increased their price target on shares of Celcuity from $150.00 to $160.00 and gave the stock a "market outperform" rating in a report on Monday...

Celcuity (NASDAQ:CELC) Reaches New 12-Month High on Analyst Upgrade

Celcuity (NASDAQ:CELC) Hits New 52-Week High on Analyst Upgrade...

"Just Another Dip Investors Will Buy": Futures Drop, Oil Rises On Renewed Iran Tension

"Just Another Dip Investors Will Buy": Futures Drop, Oil Rises On Renewed Iran Tension

 US futures whipsawed and crude oil spiked higher as tensions flared up again in the Middle East, taking the focus off a run of strong earnings by megacap tech companies. As of 8:00am ET, S&P and...

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$87.76
Prev Close	$88.05
Open	$88.17
Dividend Yield	0.00%
50-Day Moving Average	$118.04
Beta	1.08
Avg. Volume	1.26M
PE Ratio	-22.52

52-Week High	$151.02
52-Week Low	$11.28
Market Capitalization	$4.29B
EPS (Annual)	-$3.79
Price to Book	79.27
Revenue Per Employee	$0.00

CELCCelcuity Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CELC News